News

24/7 Wall St. on MSN56m
4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential
After underperforming the overall market for the past few years, large-cap pharmaceutical stocks may now be positioned to ...
Santé log56m
FDA Approves SKYTROFA® (Lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency
The FDA’s approval of SKYTROFA for adult GHD was based on results from foresiGHt, a Phase 3 randomized, parallel-arm, placebo-controlled (double-blind) and active-controlled (open-label) clinical ...